Skip to main content
. 2015 May 22;10(5):e0127732. doi: 10.1371/journal.pone.0127732

Fig 2. Sensitivity and specificity of biomarkers in plasma: C22-Cer and C24:1-Cer.

Fig 2

We demonstrated a significantly higher risk of Down Syndrome when the plasma concentration of C22-Cer > 12.66 ng/100ul (sens. 0.9, sp. 0.79, P value = 0.0007) and C24:1-Cer > 33,19 ng/100ul (sens. 0.6, sp. 0.86, P value = 0.0194).